Latest Headlines
-
New Tuberculosis Test Could Improve TB Care Globally By Increasing Access To Testing In Low- And Middle-Income Countries
3/14/2024
A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine's (formerly AACC's) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.
-
Fabric Genomics Partners With Intermountain Children’s Health To Enhance Precision Diagnosis Of Infants And Children Using Whole Genome Sequencing From Broad Clinical Labs
3/13/2024
Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
-
Physicians Lab Launches The First-Of-Its-Kind At-Home Lab Test For Myostatin And Follistatin Levels
3/13/2024
Physicians Lab, a provider of at-home lab testing for integrative medicine and wellness, launched a new at-home lab test that measures the analytes myostatin and follistatin.
-
Beckman Coulter And Fujirebio Expand Partnership To Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Capital Digestive Care Launches AI-Driven LGI-Flag Algorithm For Predicting Lower Gastrointestinal Disorders Including Colorectal Cancer In The United States
3/12/2024
Capital Digestive Care, the largest private gastroenterology (GI) practice in the Mid-Atlantic region, today announced that it is launching LGI-Flag in the United States.
-
Roche Showcases New Navify® Digital Solutions That Generate Operational Insights For Faster Decision-Making In Diagnostics At HIMSS1 2024
3/12/2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) introduces navify Analytics, its suite of cloud-based solutions that provide actionable insights to optimise operational and financial outcomes in laboratories and point of care (POC) settings. navify Analytics for POC will make its debut at the HIMSS 2024 Conference in Orlando, USA, from 11-15 March 2024.
-
Philips And AWS Collaborate To Scale Digital Pathology In The Cloud, Enhancing Diagnostic Capabilities And Improving Productivity
3/12/2024
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to address the growing need for secure, scalable digital pathology solutions in the cloud.
-
Wolters Kluwer Strengthens Clinical GenAI Market Leadership With AI Labs Powered By Uptodate
3/11/2024
Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate, the globally trusted clinical decision support (CDS) solution.
-
Ideal Option Opens Largest Outpatient Addiction Clinic And Lab In King County
3/11/2024
Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, has opened a 13,000-square-foot facility in Renton combining low-barrier treatment services with a state-of-the-art laboratory and community resource center.
-
The Jackson Laboratory And LG AI Research Partner To Pioneer Biomedical Advancements
3/11/2024
What can happen when prominent institutions in technology and research form a partnership to accelerate the implementation of artificial intelligence (AI) to enhance biomedical research and clinical care? A recent agreement in the field carries with it lofty aspirations.